Astera Labs (NASDAQ:ALAB) Shares Up 4% – Here’s What Happened

Shares of Astera Labs, Inc. (NASDAQ:ALABGet Free Report) traded up 4% during trading on Wednesday . The company traded as high as $309.67 and last traded at $300.54. 3,041,083 shares traded hands during trading, a decline of 43% from the average daily volume of 5,303,669 shares. The stock had previously closed at $288.85.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on ALAB shares. Morgan Stanley lifted their price objective on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Stifel Nicolaus increased their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. TD Cowen reduced their price target on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Finally, Bank of America lifted their price target on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $348.33.

View Our Latest Analysis on Astera Labs

Astera Labs Price Performance

The company has a market cap of $50.55 billion, a P/E ratio of 144.00 and a beta of 3.77. The company has a 50 day moving average of $318.90 and a 200-day moving average of $259.95.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insiders Place Their Bets

In other news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the sale, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 592,244 shares of company stock worth $209,729,973. 10.40% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds and other institutional investors have recently modified their holdings of ALAB. Eurizon Capital SGR S.p.A. purchased a new position in shares of Astera Labs in the fourth quarter valued at about $18,708,000. Swedbank AB boosted its stake in shares of Astera Labs by 76.8% in the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares during the period. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in shares of Astera Labs during the fourth quarter worth about $499,000. Revere Asset Management Inc purchased a new stake in shares of Astera Labs during the fourth quarter worth about $589,000. Finally, Banque Cantonale Vaudoise raised its stake in Astera Labs by 85.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 6,990 shares of the company’s stock valued at $766,000 after purchasing an additional 3,229 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.

Featured Articles

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.